Robyn Mitchell
Overview
Explore the profile of Robyn Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Choi K, Steele V, Conly J, Chow B, Comeau J, Embree J, et al.
Infect Control Hosp Epidemiol
. 2022 Jun;
44(6):971-974.
PMID: 35708283
Cerebrospinal fluid shunt-associated surgical site infection surveillance for 3 months compared to 12 months after surgery captures 83% of cases with no significant differences in patient characteristics, surgery types, or...
12.
Kleinman D, Mitchell R, McCracken M, Hota S, Golding G, Smith S
Infect Control Hosp Epidemiol
. 2022 Mar;
44(1):17-23.
PMID: 35264277
Objective: To analyze the spread of a novel sequence type (ST1478) of vancomycin-resistant across Canadian hospitals. Design: Retrospective chart review of patients identified as having ST1478 VRE bloodstream infection. Setting:...
13.
Liang J, Rudnick W, Mitchell R, Brooks J, Bush K, Conly J, et al.
Infect Control Hosp Epidemiol
. 2022 Mar;
43(11):1558-1564.
PMID: 35249564
Objectives: The Canadian Nosocomial Infection Surveillance Program conducted point-prevalence surveys in acute-care hospitals in 2002, 2009, and 2017 to identify trends in antimicrobial use. Methods: Eligible inpatients were identified from...
14.
Mitchell R, Choi K, Pelude L, Rudnick W, Thampi N, Taylor G
CMAJ Open
. 2021 Mar;
9(1):E149-E156.
PMID: 33653770
Background: Information on the epidemiology of patients in hospital with laboratory-confirmed coronavirus disease 2019 (COVID-19) in Canadian acute care hospitals is needed to inform infection prevention and control strategies and...
15.
McCracken M, Mitchell R, Smith S, Hota S, Conly J, Du T, et al.
Emerg Infect Dis
. 2020 Aug;
26(9):2247-2250.
PMID: 32818423
Rates of vancomycin-resistant enterococci bloodstream infections have remained relatively low in Canada. We recently observed an increase of 113% in these infections rates, which coincided with emergence of Enterococcus faecium...
16.
Garcia-Jeldes H, Mitchell R, McGeer A, Rudnick W, Amaratunga K, Vallabhaneni S, et al.
Antimicrob Resist Infect Control
. 2020 Jun;
9(1):82.
PMID: 32522237
To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism...
17.
Garcia-Jeldes F, Mitchell R, Bharat A, McGeer A
Infect Control Hosp Epidemiol
. 2020 Jan;
41(3):361-364.
PMID: 31928546
We surveyed Canadian Nosocomial Infection Surveillance Program hospitals to evaluate infection prevention and microbiology laboratory preparedness for Candida auris. We identified significant gaps: most hospitals were not prepared to screen...
18.
Mitchell R, Taylor G, Rudnick W, Alexandre S, Bush K, Forrester L, et al.
CMAJ
. 2019 Sep;
191(36):E981-E988.
PMID: 31501180
Background: Health care-associated infections are a common cause of patient morbidity and mortality. We sought to describe the trends in these infections in acute care hospitals, using data from 3...
19.
Boyd D, Mataseje L, Pelude L, Mitchell R, Bryce E, Roscoe D, et al.
J Antimicrob Chemother
. 2018 Oct;
74(2):315-320.
PMID: 30312401
Objectives: Globally there is an increased prevalence of carbapenem-resistant Acinetobacter spp. (CRAs) and carbapenemase-producing Acinetobacter spp. (CPAs) in the hospital setting. This increase prompted the Canadian Nosocomial Infection Surveillance Program...
20.
Roth V, Mitchell R, Vachon J, Alexandre S, Amaratunga K, Smith S, et al.
Infect Control Hosp Epidemiol
. 2016 Nov;
38(2):147-153.
PMID: 27834161
BACKGROUND Hip and knee arthroplasty infections are associated with considerable healthcare costs. The merits of reducing the postoperative surveillance period from 1 year to 90 days have been debated. OBJECTIVES...